4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-021844
Chief Executive Officer sold 8,800 shares at an average $38.59 ($339,549)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-03-26 | Sale | −3,200 | $39.72 | $127,104 | 212,078 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-03-26 | Sale | −1,200 | $41.12 | $49,344 | 210,878 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-03-27 | Sale | −2,700 | $36.63 | $98,901 | 208,178 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-03-27 | Sale | −1,500 | $37.68 | $56,520 | 206,678 | I: show line 4 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-03-27 | Sale | −200 | $38.40 | $7,680 | 206,478 | D: show line 5 in the form |
| Open-market sales · 8,800 sh · avg $38.59 · $339,549 | |||||||
Loading xslF345X03/doc4.xml…